213 related articles for article (PubMed ID: 30082086)
1. Complications of transarterial chemoembolization (TACE) in the treatment of liver tumors.
Marcacuzco Quinto A; Nutu OA; San Román Manso R; Justo Alonso I; Calvo Pulido J; Manrique Municio A; García-Sesma Á; Loinaz Segurola C; Martínez Caballero J; Jiménez Romero LC
Cir Esp (Engl Ed); 2018 Nov; 96(9):560-567. PubMed ID: 30082086
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis.
Sneiders D; Boteon APCS; Lerut J; Iesari S; Gilbo N; Blasi F; Larghi Laureiro Z; Orlacchio A; Tisone G; Lai Q; Pirenne J; Polak WG; Perera MTPR; Manzia TM; Hartog H
Br J Surg; 2021 Nov; 108(11):1323-1331. PubMed ID: 34611694
[TBL] [Abstract][Full Text] [Related]
3. The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study.
Pipa-Muñiz M; Castells L; Pascual S; Fernández-Castroagudín J; Díez-Miranda I; Irurzun J; Díaz-Beveridge R; Senosiaín M; Arenas J; de la Mata M; Turnes J; Monge-Romero MI; Pérez-Enguix D; Bustamante-Schneider J; Otegui N; Molina-Pérez E; Rodríguez-Menéndez JE; Varela M
Gastroenterol Hepatol; 2017 Oct; 40(8):515-524. PubMed ID: 28676199
[TBL] [Abstract][Full Text] [Related]
4. Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization.
Yoo SH; Jang JW; Kwon JH; Jung SM; Jang B; Choi JY
Clin Mol Hepatol; 2016 Dec; 22(4):458-465. PubMed ID: 28081589
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for the Development of Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma Treatment.
Lima M; Dutra S; Gomes FV; Bilhim T; Coimbra É
Acta Med Port; 2018 Jan; 31(1):22-29. PubMed ID: 29573765
[TBL] [Abstract][Full Text] [Related]
6. Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer.
Xia J; Ren Z; Ye S; Sharma D; Lin Z; Gan Y; Chen Y; Ge N; Ma Z; Wu Z; Fan J; Qin L; Zhou X; Tang Z; Yang B
Eur J Radiol; 2006 Sep; 59(3):407-12. PubMed ID: 16621394
[TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
8. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
[TBL] [Abstract][Full Text] [Related]
9. The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma.
Tu J; Jia Z; Ying X; Zhang D; Li S; Tian F; Jiang G
Medicine (Baltimore); 2016 Dec; 95(49):e5606. PubMed ID: 27930585
[TBL] [Abstract][Full Text] [Related]
10. Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.
Monier A; Guiu B; Duran R; Aho S; Bize P; Deltenre P; Dunet V; Denys A
Eur Radiol; 2017 Apr; 27(4):1431-1439. PubMed ID: 27436016
[TBL] [Abstract][Full Text] [Related]
11. [Transarterial chemoembolization of liver metastases of colorectal carcinoma using degradable starch microspheres (Spherex): personal investigations and review of the literature].
Wasser K; Giebel F; Fischbach R; Tesch H; Landwehr P
Radiologe; 2005 Jul; 45(7):633-43. PubMed ID: 15316615
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
Xue T; Le F; Chen R; Xie X; Zhang L; Ge N; Chen Y; Wang Y; Zhang B; Ye S; Ren Z
Med Oncol; 2015 Mar; 32(3):64. PubMed ID: 25682389
[TBL] [Abstract][Full Text] [Related]
13. Biliary complications of arterial chemoembolization of hepatocellular carcinoma.
Dhamija E; Paul SB; Gamanagatti SR; Acharya SK
Diagn Interv Imaging; 2015 Nov; 96(11):1169-75. PubMed ID: 26292615
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization for liver metastases of a pancreatic neuroendocrine neoplasm: a single-center experience.
Nanno Y; Toyama H; Ueshima E; Sofue K; Matsumoto I; Ishida J; Urade T; Fukushima K; Gon H; Tsugawa D; Komatsu S; Kuramitsu K; Goto T; Asari S; Yanagimoto H; Kido M; Ajiki T; Fukumoto T
Surg Today; 2023 Dec; 53(12):1396-1400. PubMed ID: 37355500
[TBL] [Abstract][Full Text] [Related]
15. [Gallbladder Perforation after Transarterial Chemoembolization in a Patient with a Huge Hepatocellular Carcinoma].
Son MY; Han BH; Lee SU; Yun BC; Seo KI; Huh JD
Korean J Gastroenterol; 2020 Jun; 75(6):351-355. PubMed ID: 32581207
[TBL] [Abstract][Full Text] [Related]
16. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
[TBL] [Abstract][Full Text] [Related]
17. [Clivus metastasis from hepatocarcinoma associated with transarterial hepatic chemoembolization].
Escarda A; Vaquer P; Bonet L; Miralbés S; Gómez C; Obrador A
Gastroenterol Hepatol; 2006; 29(7):401-4. PubMed ID: 16938255
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of clinical prognosis and the correlation between bile duct injury after transcatheter arterial chemoembolization and the level of hepatic arterial embolization in patients with hepatocellular carcinoma].
Xu HY; Yu XP; Feng R; Hu HJ; Xiao WW
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):355-360. PubMed ID: 28535652
[No Abstract] [Full Text] [Related]
19. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
Zhang DZ; Wei XD; Wang XP
World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
